{"product_id":"first-line-therapy-in-multiple-myeloma-von-ahmed-rabea","title":"First line therapy in Multiple Myeloma","description":"\u003cp\u003eIn the past, survival in Multiple Myeloma was in the range of 1 to 3 years. With the introduction of the novel drugs as the immunomodulators (IMiDs) and Proteosome inhibitors, survival has markedly increased and quality of life has improved. In this book, I have given an overview of the novel drugs and their use as first line therapy in multiple myeloma aiming for better prognosis, survival and quality of life.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783846557945\"\u003e\u003ch3\u003eOverview of recent therapy in treatment of new Multiple Myeloma patients\u003c\/h3\u003e\u003c\/div\u003e","brand":"Autorenwelt Shop","offers":[{"title":"Softcover - 9783846557945","offer_id":39494505431133,"sku":"9783846557945","price":59.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/54902dc6-9520-482f-ae86-c3d6272b3a89.jpg?v=1770445155","url":"https:\/\/shop.autorenwelt.de\/en\/products\/first-line-therapy-in-multiple-myeloma-von-ahmed-rabea","provider":"Autorenwelt Shop","version":"1.0","type":"link"}